{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T20:56:17Z","timestamp":1764276977810,"version":"3.37.3"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"the Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["16810055"],"award-info":[{"award-number":["16810055"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>The pathology of gouty arthritis and reactive arthritis (ReA) partially overlaps, and both diseases are characterized by the production of inflammatory cytokines associated with the activation of monocytes and macrophages. However, the precise cytokine profile of cases with a coexistence of both diseases is unknown, and there are few reports on the course of treatment in patients with both gouty arthritis and ReA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 39-year-old man with a recurrent episode of gouty arthritis presented prednisolone-resistant polyarthritis with high level of C-reactive protein (CRP). He had the features of gouty arthritis such as active synovitis of the first manifestation of metatarsophalangeal (MTP) joints and the presence of monosodium urate (MSU) crystals from synovial fluid. But he also had the features of ReA such as the presence of tenosynovitis in the upper limb, the positivity of human leukocyte antigen (HLA)-B27, a history of sexual contact and positive findings of anti-<jats:italic toggle=\"yes\">Chlamydia trachomatis<\/jats:italic>-specific IgA and IgG serum antibodies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>He was diagnosed with HLA-B27 associated Chlamydia-induced ReA accompanied by gout flares.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>He was treated with 180\u200amg\/day of loxoprofen, 1\u200amg\/day of colchicine, and 10\u200amg\/day of prednisolone for gout flares. However, his polyarthritis worsened with an increased level of CRP (23.16\u200amg\/dL). Accordingly, we added 500\u200amg\/day of salazosulfapyridine followed by adalimumab (ADA) 40\u200amg once every 2 weeks.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After starting ADA, the patient's symptoms and laboratory findings showed rapid improvement and he achieved clinical remission 1 month after initiation of ADA treatment. As of this writing, the patient's clinical remission has been maintained for &gt;1 year.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case suggests that with exacerbation of arthritis during gouty arthritis, coexistence with other pathologies such as peripheral spondyloarthritis should be considered, and early intensive treatment including tumor necrosis factor inhibitors may be necessary.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000017233","type":"journal-article","created":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T15:13:51Z","timestamp":1570029231000},"page":"e17233","source":"Crossref","is-referenced-by-count":5,"title":["Chlamydia-induced reactive arthritis diagnosed during gout flares"],"prefix":"10.1097","volume":"98","author":[{"given":"Remi","family":"Sumiyoshi","sequence":"first","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Koga","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"},{"name":"Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sosuke","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushiro","family":"Endo","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayuko","family":"Takatani","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimasa","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Igawa","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Umeda","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"},{"name":"Medical Education Development Center, Nagasaki University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Fukui","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Nishino","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"},{"name":"Center for Comprehensive Community Care Education"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ya","family":"Kawashiri","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"},{"name":"Department of Community Medicine, Unit of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Ichinose","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Tamai","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Origuchi","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,10]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1754-9485.12356","article-title":"Gouty arthropathy: review of clinico-pathologic and imaging features","volume":"60","author":"Parathithasan","year":"2016","journal-title":"J Med Imaging Radiat Oncol"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jare.2017.04.008","article-title":"Gout: an old disease in new perspective \u2013 a review","volume":"8","author":"Ragab","year":"2017","journal-title":"J Adv Res"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.autrev.2014.01.005","article-title":"Diagnosis and classification of reactive arthritis","volume":"13","author":"Selmi","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.berh.2006.02.003","article-title":"Reactive arthritis or post-infectious arthritis?","volume":"20","author":"Hannu","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/ard.2003.010710","article-title":"Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study","volume":"63","author":"Kvien","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"e3449","DOI":"10.1097\/MD.0000000000003449","article-title":"Multiple serum cytokine profiling to identify combinational diagnostic biomarkers in attacks of familial mediterranean fever","volume":"95","author":"Koga","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2147\/JPR.S133572","article-title":"Gout mimicking spondyloarthritis: case report and literature review","volume":"10","author":"Chen","year":"2017","journal-title":"J Pain Res"},{"key":"R8-20230915","first-page":"227","article-title":"Decreasing prevalence of tophaceous gout","volume":"50","author":"O\u2019Duffy","year":"1975","journal-title":"Mayo Clin Proc"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/art.1780160402","article-title":"The past four decades of progress in the knowledge of gout, with an assessment of the present status","volume":"16","author":"Gutman","year":"1973","journal-title":"Arthritis Rheum"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/art.1780310410","article-title":"Ten-year follow-up study of patients with Yersinia arthritis","volume":"31","author":"Leirisalo-Repo","year":"1988","journal-title":"Arthritis Rheum"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/art.30272","article-title":"Safety and efficacy of anti-tumor necrosis factor alpha therapy in ten patients with recent-onset refractory reactive arthritis","volume":"63","author":"Meyer","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jaci.2009.11.001","article-title":"Therapy of autoinflammatory syndromes","volume":"124","author":"Hoffman","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"(Suppl 3)","key":"R14-20230915","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1186\/ar571","article-title":"HLA-B27: natural function and pathogenic role in spondyloarthritis","volume":"4","author":"McMichael","year":"2002","journal-title":"Arthritis Res"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5411\/wji.v4.i2.78","article-title":"Immunopathogenesis of reactive arthritis: role of the cytokines","volume":"4","author":"Eli\u00e7abe","year":"2014","journal-title":"World J Immuol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T21:42:10Z","timestamp":1694814130000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017233"}},"subtitle":["A case report and cumulative effect of inflammatory cytokines on chronic arthritis"],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":15,"journal-issue":{"issue":"40","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017233","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}